Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct;71(4):579-589.
doi: 10.1007/s11418-017-1104-7. Epub 2017 Jul 5.

Naturally occurring Vpr inhibitors from medicinal plants of Myanmar

Affiliations
Review

Naturally occurring Vpr inhibitors from medicinal plants of Myanmar

Nwet Nwet Win et al. J Nat Med. 2017 Oct.

Erratum in

Abstract

Human immunodeficiency virus type-1 (HIV-1) is a lentiviral family member that encodes the retroviral Gag, Pol, and Env proteins, along with six additional accessory proteins, Tat, Rev, Vpu, Vif, Nef, and Vpr. The currently approved anti-HIV drugs target the Pol and Env encoded proteins. However, these drugs are only effective in reducing viral replication. Furthermore, the drugs' toxicities and the emergence of drug-resistant strains have become serious worldwide problems. Resistance eventually arises to all of the approved anti-HIV drugs, including the newly approved drugs that target HIV integrase (IN). Drug resistance likely emerges because of spontaneous mutations that occur during viral replication. Therefore, new drugs that effectively block other viral components must be developed to reduce the rate of resistance and suppress viral replication with little or no long-term toxicity. The accessory proteins may expand treatment options. Viral protein R (Vpr) is one of the promising drug targets among the HIV accessory proteins. However, the search for inhibitors continues in anti-HIV drug discovery. In this review, we summarize the naturally occurring compounds discovered from two Myanmar medicinal plants as well as their structure-activity relationships. A total of 49 secondary metabolites were isolated from Kaempferia pulchra rhizomes and Picrasama javanica bark, and the types of compounds were identified as isopimarane diterpenoids and picrasane quassinoids, respectively. Among the isolates, 7 diterpenoids and 15 quassinoids were found to be Vpr inhibitors lacking detectable toxicity, and their potencies varied according to their respective functionalities.

Keywords: Isopimarane diterpenoids; K. pulchra; P. javanica; Picrasane quassinoids; TREx-HeLa-Vpr cells; Viral protein R.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Structures of compounds isolated from K. pulchra rhizomes
Fig. 2
Fig. 2
The inhibitory effects of a the CHCl3-soluble extract of K. pulchra and b the potent compounds and the positive control damnacanthal against the expression of Vpr in TREx-HeLa-Vpr cells
Fig. 3
Fig. 3
Structures of compounds isolated from P. javanica bark
Fig. 4
Fig. 4
The inhibitory effects of a the CHCl3-soluble extract of P. javanica and b the isolated compounds and the positive control damnacanthal against the expression of Vpr in TREx-HeLa-Vpr cells

References

    1. UNAIDS (2106), Global AIDS update 2016: 1 16
    1. FDA approves maraviroc tablets (2007) AIDS patient care STDs 21:702 - PubMed
    1. FDA notification Accelerated approval for raltegravir tablets. AIDS Alert. 2007;22:143–144. - PubMed
    1. Richter SN, Frasson I, Palù G. Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy? Curr Med Chem. 2009;16:267–286. doi: 10.2174/092986709787002646. - DOI - PubMed
    1. Berrey MM, Schacker T, Collier AC, Shea T, Brodie SJ, Mayers D, Coombs R, Krieger J, Chun TW, Fauci A, Self SG, Corey L. Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. J Infect Dis. 2001;183:1466–1475. doi: 10.1086/320189. - DOI - PubMed

MeSH terms

LinkOut - more resources